Cargando…

Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer

Hippo signaling has been recognized as a key tumor suppressor pathway. Here, we perform a comprehensive molecular characterization of 19 Hippo core genes in 9,125 tumor samples across 33 cancer types using multidimensional “omic” data from The Cancer Genome Atlas. We identify somatic drivers among H...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yumeng, Xu, Xiaoyan, Maglic, Dejan, Dill, Michael T., Mojumdar, Kamalika, Ng, Patrick Kwok-Shing, Jeong, Kang Jin, Tsang, Yiu Huen, Moreno, Daniela, Bhavana, Venkata Hemanjani, Peng, Xinxin, Ge, Zhongqi, Chen, Hu, Li, Jun, Chen, Zhongyuan, Zhang, Huiwen, Han, Leng, Du, Di, Creighton, Chad J., Mills, Gordon B., Camargo, Fernando, Liang, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326181/
https://www.ncbi.nlm.nih.gov/pubmed/30380420
http://dx.doi.org/10.1016/j.celrep.2018.10.001
_version_ 1783386256821977088
author Wang, Yumeng
Xu, Xiaoyan
Maglic, Dejan
Dill, Michael T.
Mojumdar, Kamalika
Ng, Patrick Kwok-Shing
Jeong, Kang Jin
Tsang, Yiu Huen
Moreno, Daniela
Bhavana, Venkata Hemanjani
Peng, Xinxin
Ge, Zhongqi
Chen, Hu
Li, Jun
Chen, Zhongyuan
Zhang, Huiwen
Han, Leng
Du, Di
Creighton, Chad J.
Mills, Gordon B.
Camargo, Fernando
Liang, Han
author_facet Wang, Yumeng
Xu, Xiaoyan
Maglic, Dejan
Dill, Michael T.
Mojumdar, Kamalika
Ng, Patrick Kwok-Shing
Jeong, Kang Jin
Tsang, Yiu Huen
Moreno, Daniela
Bhavana, Venkata Hemanjani
Peng, Xinxin
Ge, Zhongqi
Chen, Hu
Li, Jun
Chen, Zhongyuan
Zhang, Huiwen
Han, Leng
Du, Di
Creighton, Chad J.
Mills, Gordon B.
Camargo, Fernando
Liang, Han
author_sort Wang, Yumeng
collection PubMed
description Hippo signaling has been recognized as a key tumor suppressor pathway. Here, we perform a comprehensive molecular characterization of 19 Hippo core genes in 9,125 tumor samples across 33 cancer types using multidimensional “omic” data from The Cancer Genome Atlas. We identify somatic drivers among Hippo genes and the related microRNA (miRNA) regulators, and using functional genomic approaches, we experimentally characterize YAP and TAZ mutation effects and miR-590 and miR-200a regulation for TAZ. Hippo pathway activity is best characterized by a YAP/TAZ transcriptional target signature of 22 genes, which shows robust prognostic power across cancer types. Our elastic-net integrated modeling further reveals cancer-type-specific pathway regulators and associated cancer drivers. Our results highlight the importance of Hippo signaling in squamous cell cancers, characterized by frequent amplification of YAP/TAZ, high expression heterogeneity, and significant prognostic patterns. This study represents a systems-biology approach to characterizing key cancer signaling pathways in the post-genomic era.
format Online
Article
Text
id pubmed-6326181
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-63261812019-01-09 Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer Wang, Yumeng Xu, Xiaoyan Maglic, Dejan Dill, Michael T. Mojumdar, Kamalika Ng, Patrick Kwok-Shing Jeong, Kang Jin Tsang, Yiu Huen Moreno, Daniela Bhavana, Venkata Hemanjani Peng, Xinxin Ge, Zhongqi Chen, Hu Li, Jun Chen, Zhongyuan Zhang, Huiwen Han, Leng Du, Di Creighton, Chad J. Mills, Gordon B. Camargo, Fernando Liang, Han Cell Rep Article Hippo signaling has been recognized as a key tumor suppressor pathway. Here, we perform a comprehensive molecular characterization of 19 Hippo core genes in 9,125 tumor samples across 33 cancer types using multidimensional “omic” data from The Cancer Genome Atlas. We identify somatic drivers among Hippo genes and the related microRNA (miRNA) regulators, and using functional genomic approaches, we experimentally characterize YAP and TAZ mutation effects and miR-590 and miR-200a regulation for TAZ. Hippo pathway activity is best characterized by a YAP/TAZ transcriptional target signature of 22 genes, which shows robust prognostic power across cancer types. Our elastic-net integrated modeling further reveals cancer-type-specific pathway regulators and associated cancer drivers. Our results highlight the importance of Hippo signaling in squamous cell cancers, characterized by frequent amplification of YAP/TAZ, high expression heterogeneity, and significant prognostic patterns. This study represents a systems-biology approach to characterizing key cancer signaling pathways in the post-genomic era. 2018-10-30 /pmc/articles/PMC6326181/ /pubmed/30380420 http://dx.doi.org/10.1016/j.celrep.2018.10.001 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Wang, Yumeng
Xu, Xiaoyan
Maglic, Dejan
Dill, Michael T.
Mojumdar, Kamalika
Ng, Patrick Kwok-Shing
Jeong, Kang Jin
Tsang, Yiu Huen
Moreno, Daniela
Bhavana, Venkata Hemanjani
Peng, Xinxin
Ge, Zhongqi
Chen, Hu
Li, Jun
Chen, Zhongyuan
Zhang, Huiwen
Han, Leng
Du, Di
Creighton, Chad J.
Mills, Gordon B.
Camargo, Fernando
Liang, Han
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
title Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
title_full Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
title_fullStr Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
title_full_unstemmed Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
title_short Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
title_sort comprehensive molecular characterization of the hippo signaling pathway in cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326181/
https://www.ncbi.nlm.nih.gov/pubmed/30380420
http://dx.doi.org/10.1016/j.celrep.2018.10.001
work_keys_str_mv AT wangyumeng comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT xuxiaoyan comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT maglicdejan comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT dillmichaelt comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT mojumdarkamalika comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT ngpatrickkwokshing comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT jeongkangjin comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT tsangyiuhuen comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT morenodaniela comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT bhavanavenkatahemanjani comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT pengxinxin comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT gezhongqi comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT chenhu comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT lijun comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT chenzhongyuan comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT zhanghuiwen comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT hanleng comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT dudi comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT creightonchadj comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT millsgordonb comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT camargofernando comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer
AT lianghan comprehensivemolecularcharacterizationofthehipposignalingpathwayincancer